fluphenazine depot and olanzapine

fluphenazine depot has been researched along with olanzapine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Conley, RR; Kelly, DL; Love, RC; McMahon, RP	1
Charles, J; Miller, G; Ng, A	1
Arellano, A; Baptista, T; Beaulieu, S; Contreras, Q; Galeazzi, T; Hernández, L; Lacruz, A; Martinez, M; Mendoza, S; Vargas, D	1
Kirk Morton, N; Zubek, D	1

Trials

1 trial(s) available for fluphenazine depot and olanzapine

Article	Year
Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia. Schizophrenia research, 2007, Volume: 89, Issue:1-3 Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Blood Glucose; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Insulin; Insulin Resistance; Male; Olanzapine; Reference Values; Risperidone; Schizophrenia; Weight Gain	2007

Article

Year

Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.

Schizophrenia research, 2007, Volume: 89, Issue:1-3

Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Blood Glucose; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Insulin; Insulin Resistance; Male; Olanzapine; Reference Values; Risperidone; Schizophrenia; Weight Gain

2007

Other Studies

5 other study(ies) available for fluphenazine depot and olanzapine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Rehospitalization risk with second-generation and depot antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2003, Volume: 15, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome	2003
Management of psychosis in Australian general practice. Australian family physician, 2006, Volume: 35, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazepines; Directive Counseling; Female; Fluphenazine; Humans; Lithium Carbonate; Male; Middle Aged; Olanzapine; Psychotic Disorders; Referral and Consultation; Sex Factors	2006
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia. Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia	2013